Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation

Biochemical and Biophysical Research Communications

Volumn 423, Issue 1, 2012, Pages 200-205

  Sato, Chieri ^a   Iwasaki, Tsuyoshi ^a   Kitano, Sachie ^a   Tsunemi, Sachi ^a   Sano, Hajime ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

ALP; BMP; ERK; FTY720; HGF; MAPK; MEK; Osteoblast; PG; Rheumatoid arthritis; S1P; Sphingosine 1 phosphate

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; FINGOLIMOD; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; OSTEOCALCIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; MOUSE; MYOBLAST; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; LYSOPHOSPHOLIPIDS; MICE; OSTEOBLASTS; OSTEOCALCIN; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SMAD PROTEINS; SPHINGOSINE;

MURINAE;

EID: 84862682840     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.130     Document Type: Article

References (39)

1. Yin T., Li L. The stem cell niches in bone. J. Clin. Invest. 2006, 116:1195-1201.
2. Lieberman J.R., Daluiski A., Einhern T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002, 84-A:1032-1044.
3. Ducy P., Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000, 57:2207-2214.
4. Singharanadgit W., Salih V., Olsen I. Up-regulation of bone morphogenic protein receptor IB by growth factors BMP-2-induced human bone cell functions. J. Cell Physiol. 2006, 209:912-922.
5. Kubota K., Iseki S., Kuroda S., Oida S., Iimura T., Duarte W.R., et al. Synergisitc effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 2002, 31:465-471.
6. Peng H., Wright V., Usas A., Gearhart B., Shen H.C., Cummins J., et al. Senergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 2002, 110:751-759.
7. Standal T., Abildgaard N., Fagerli U.M., Stordal B., Hertner O., Borset M., et al. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood 2007, 190:3024-3030.
8. Kawasaki T., Niki Y., Miyamoto T., Horiuchi K., Matsumoto M., Aizawa M., et al. The effect of timing in the administration of hepatocyte growth factor to modulate BMP-2-induced osteoblast differentiation. Biomaterials 2010, 31:1191-1198.
9. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
10. Kitano M., Hla T., Sekiguchi M., Kawahito Y., Yoshimura R., Miyazawa K., et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 2006, 54:742-753.
11. Meacci E., Nuti F., Donati C., Cencetti F., Farnararo M., Bruni P. Sphingosine kinase activity is required for myogenic differentiation of C2C12 myoblasts. J. Cell Physiol. 2008, 214:210-220.
12. Donati C., Meacci E., Nuti F., Becciolini L., Farnararo M., Bruni P. Sphingosine 1-phosphate regulates myogenic differentiation:a major role for S1P2 receptor. FASEB J. 2005, 19:449-451.
13. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 12:1755-1766.
14. 1 agonist that does not require S1P-like head-group interactions. Mol. Pharmacol. 2008, 74:1308-1318.
15. Ohmoria T., Yatomia Y., Osadaa M., Kazama F., Takafuta T., Ikeda H., et al. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovas. Res. 2003, 58:170-177.
16. Tao R., Hoover H.E., Honbo N., Kalinowski M., Alano C.C., Karliner J.S., et al. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H1022-H1028.
17. Komori T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lingage. J. Cell Biol. 1994, 12:1755-1766.
18. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, acandidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
19. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell Biol. 2000, 20:8783-8792.
20. Hanai J., Chen L.F., Kanno T., Ohtani-Fujita N., Kim W.Y., Guo W.H., et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 1999, 274:31577-31582.
21. Lee M.J., Thangada S., Claffey K.P., Ancellin N., Liu C.H., Kluk M.J. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999, 99:301-312.
22. Hla T., Lee M.J., Ancellin N., Paik J.H., Kluk M.J. Lysophospholipids: receptor revelations. Science 2001, 294:1875-1878.
23. Brinkmann V., Davis M.D., Heise C.E., Alber R., Cottens S., Hof R., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 2002, 277:21453-21457.
24. Tsunemi S., Iwasaki T., Kitano S., Imado T., Miyazawa K., Sano H. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model. Clin. Immunol. 2010, 136:197-204.
25. Sorensen S.D., Nicole O., Peavy R.D., Montoya L.M., Lee C.J., Murphy T.J., et al. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol. Parmacol. 2003, 64:1199-1209.
26. Bassi R., Anelli V., Giussani P., Tettamanti G., Viani P., Riboni L. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through G(i)-protein-coupled receptors. Glia 2006, 53:621-630.
27. Xin C., Ren S., Eberhardt W., Pfeilschifter J., Huwiler A. The immunomodulator FTY720 and its phosphorylated derivative activated the Smad signaling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells. Br. J. Pharmacol. 2006, 147:164-174.
28. Sancez T., Estrada-Hernandez T., Paik J.H., Wu M.T., Venkataraman K., Brinkmann V.V., et al. Phospholylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vasucular permeability. J. Biol. Chem. 2003, 278:47281-47290.
29. Celil A.B., Campbell P.G. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J. Biol. Chem. 2005, 280:31353-31359.
30. Yue J., Mulder K.M. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Meth. Mol. Biol. 2000, 142:125-131.
31. Yokymvych I., Ten Dijke P., Heldin C.H., Souchelnytskyi S. Regulation of Smad signaling by protein kinase C. FASEB J. 2001, 15:553-555.
32. Ge C., Xiao G., Jiang D. Franceshi RT, Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell Biol. 2007, 176:709-718.
33. Jun J.H., Yoon W.J., Seo S.B., Woo K.M., Kim G.S., Ryoo H.M., et al. BMP2 activated Erk/MAP kinase stabilize Runx2 by increasing p300 levels and histone acetyltransferase activity. J. Biol. Chem. 2010, 285:36410-36419.
34. Osinde M., Mullershausen F., Dev K.K. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 2007, 52:1210-1218.
35. Im D.S. Discovery of new G protein-coupled receptors for lipid mediators. J. Lipid Res. 2004, 45:410-418.
36. Paugh S.W., Cassidy M.P., He H., Milstien S., Sim-Selley L.J., Spiegel S., et al. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor. Mol. Pharmacol. 2006, 70:41-50.
37. Long J.S., Fujiwara Y., Edwards J., Tannahill C.L., Tigyi G., Pyne S., et al. Sphingosine 1-Phosphate Receptor 4 Uses HER2 (ERBB2) to regulate etracellular signal regulated kinase-1/2 in MDA-MB-453 Breast Cancer Cells. J. Biol Chem. 2010, 285:35957-35966.
38. Ryu J., Kim H.J., Chang E.J., Huang H., Banno Y., Kim H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 2006, 25:5840-5851.
39. Ishii M., Egen J.G., Klauschen F., Meier-Schellersheim M., Saeki Y., Vacher J., et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 2009, 458:524-528.